work atmosphere prioritized over salary by swiss employees according to study

Swiss economists at UBS predict stagnation in the economy for 2025 and 2026, attributing this to US President Donald Trump's tariffs, which are expected to negatively impact around 70% of Swiss companies involved in foreign trade. Growth is projected at just 1% in 2025 and 1.2% in 2026, with unemployment likely to rise above 3%. Meanwhile, a study reveals that Swiss employees prioritize a positive work atmosphere over salary.

ubs lowers goodrx price target while maintaining neutral rating

UBS has lowered its price target for GoodRx (GDRX) from $6 to $5.25 while maintaining a Neutral rating. Analysts project an average target price of $6.33, indicating a potential upside of 45.59% from the current price of $4.35. GoodRx reported a 3% revenue increase to $203 million and an 11% rise in adjusted EBITDA to $69.8 million for the first quarter, alongside strategic leadership appointments and a new e-commerce solution to enhance growth.

ubs lowers price target for getty realty while maintaining neutral rating

UBS has lowered its price target for Getty Realty (GTY) from $32 to $29 while maintaining a Neutral rating. Analysts project an average target price of $32.50, indicating a potential upside of 13.92% from the current price of $28.53. Positive developments include a 14.5% increase in annualized base rent and a strong occupancy rate of 99.7%.

fox corp reports strong revenue growth and boosts advertising performance

UBS has raised its price target for Fox Corp. to $63, maintaining a "Buy" rating, citing growth potential from its focus on news and sports content. The company reported a 27% increase in total revenue, with advertising revenue soaring by 65%, largely due to the Super Bowl, which attracted a record 128 million viewers. Fox also achieved a record quarterly free cash flow of over $1.9 billion, underscoring its strong financial health.

realty income price target lowered by ubs but maintains buy rating

UBS has reduced its price target for Realty Income (O) from $64 to $62 while maintaining a Buy rating, reflecting confidence in the stock amid market fluctuations. Analysts project an average target price of $60.92, suggesting an 8.90% upside from the current price of $55.94. The company reported a 2.9% year-over-year growth in AFFO per share, reaching $1.06, and achieved a total operational return of 8.9% for the quarter, with a portfolio occupancy rate of 98.5%.

AMN Healthcare stock target price lowered by UBS amid mixed performance results

UBS has revised its price target for AMN Healthcare from $30 to $25.50 while maintaining a Neutral stance. Analysts project an average target price of $27.29, indicating a potential upside of 20.57% from the current price of $22.63. Positive developments include exceeding revenue expectations at $690 million and a $60 million reduction in debt, despite declines in various revenue segments.

ubs lowers price target for repay holdings while maintaining neutral rating

UBS has lowered its price target for Repay Holdings (RPAY) from $7.50 to $4.50 while maintaining a Neutral rating. Analysts project an average target price of $8.36, indicating a potential upside of 107.02% from the current price of $4.04. Despite a 4% revenue decline year-over-year, the company reported strong adjusted EBITDA margins of 43% and a 19% increase in instant funding transaction volume.

ubs lowers nnn reit price target while maintaining neutral outlook

UBS analyst Michael Goldsmith has lowered the price target for NNN REIT from $44 to $43 while maintaining a Neutral outlook. The average target from 17 analysts is $44.44, suggesting a 7.09% upside from the current price of $41.50. NNN REIT reported a strong Q1 2025 with core FFO and AFFO both up 3.6% year-over-year, a high occupancy rate of 97.7%, and a solid balance sheet with $1.1 billion available on its credit line.

barclays upgrades stanley black and decker amid shifting fund sentiment

Barclays upgraded Stanley Black & Decker's outlook from Equal-Weight to Overweight on May 13, 2025. Institutional ownership saw a slight decrease in the number of funds, but total shares owned increased by 11.54% to 179,282K shares over the last three months. Notable changes include Capital Research Global Investors increasing its stake by 52.44% and AMRMX - American Mutual Fund boosting its holdings by 55.65%.

ubs maintains neutral rating on jenoptik with target price of 19 euros

UBS has maintained a "Neutral" rating on Jenoptik, setting a target price of 19 euros, following disappointing quarterly results that significantly missed profit expectations. The technology group experienced a notably weak start to the year, as reported by analyst Olivier Calvet.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:
s

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings